Herb-drug interactions: A short review on central and peripheral nervous system drugs

被引:1
作者
Bernardo, Joao [1 ]
Valentao, Patricia [1 ]
机构
[1] Univ Porto, Fac Farm, Dept Quim, REQUIMTE LAQV,Lab Farmacognosia, Rua Jorge Viterbo Ferreira 228, P-4050313 Porto, Portugal
关键词
central nervous system drugs; herb-drug interactions; medicinal plants; peripheral nervous system medications; pharmacodynamics; pharmacokinetics; ST-JOHNS-WORT; GINKGO-BILOBA EXTRACT; KAVA PIPER-METHYSTICUM; GRAPEFRUIT JUICE; IN-VITRO; CYTOCHROME-P450; ACTIVITY; ORAL BIOAVAILABILITY; WESTERN MEDICINES; P-GLYCOPROTEIN; DOUBLE-BLIND;
D O I
10.1002/ptr.8120
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herbal medicines are widely perceived as natural and safe remedies. However, their concomitant use with prescribed drugs is a common practice, often undertaken without full awareness of the potential risks and frequently without medical supervision. This practice introduces a tangible risk of herb-drug interactions, which can manifest as a spectrum of consequences, ranging from acute, self-limited reactions to unpredictable and potentially lethal scenarios. This review offers a comprehensive overview of herb-drug interactions, with a specific focus on medications targeting the Central and Peripheral Nervous Systems. Our work draws upon a broad range of evidence, encompassing preclinical data, animal studies, and clinical case reports. We delve into the intricate pharmacodynamics and pharmacokinetics underpinning each interaction, elucidating the mechanisms through which these interactions occur. One pressing issue that emerges from this analysis is the need for updated guidelines and sustained pharmacovigilance efforts. The topic of herb-drug interactions often escapes the attention of both consumers and healthcare professionals. To ensure patient safety and informed decision-making, it is imperative that we address this knowledge gap and establish a framework for continued monitoring and education. In conclusion, the use of herbal remedies alongside conventional medications is a practice replete with potential hazards. This review not only underscores the real and significant risks associated with herb-drug interactions but also underscores the necessity for greater awareness, research, and vigilant oversight in this often-overlooked domain of healthcare.
引用
收藏
页码:1903 / 1931
页数:29
相关论文
共 243 条
  • [1] A review on the recent application of ketamine in management of anesthesia, pain, and health care
    Abdollahpour, Abolfazl
    Saffarieh, Elham
    Zoroufchi, Babak Hosseinzadeh
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (03) : 1317 - 1324
  • [2] Herbal medication: potential for adverse interactions with analgesic drugs
    Abebe, W
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (06) : 391 - 401
  • [3] Cannabinoid-Opioid Interaction in Chronic Pain
    Abrams, D. I.
    Couey, P.
    Shade, S. B.
    Kelly, M. E.
    Benowitz, N. L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (06) : 844 - 851
  • [4] Ahmed S, 2014, PAK J PHARM SCI, V27, P1583
  • [5] Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy
    Ahn, James
    Ahn, Hyung Seok
    Cheong, Jae Hoon
    dela Pena, Ike
    [J]. NEURAL PLASTICITY, 2016, 2016
  • [6] An update on the clinical pharmacokinetics of fexofenadine enantiomers
    Akamine, Yumiko
    Miura, Masatomo
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (04) : 429 - 434
  • [7] Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
    Alda, M.
    [J]. MOLECULAR PSYCHIATRY, 2015, 20 (06) : 661 - 670
  • [8] Alhumayyd MS, 2014, J PHYSIOL PHARMACOL, V65, P785
  • [9] Coma from the health food store: Interaction between kava and alprazolam
    Almeida, JC
    Grimsley, EW
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (11) : 940 - 941
  • [10] Alzubaidi FA, 2015, AM J PHARM SCI, V3, P7